Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ceri Davies (London, United Kingdom), Ceri Davies, Jo Ann Rhodes, Peter Barnes, Louise Donnelly. Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists. Eur Respir J 2015; 46: Suppl. 59, 3900

Member's Comments

No comment yet.

Related content which might interest you: Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Source: Eur Respir J 2008; 31: 783-789 Year: 2008 Elevated GM-CSF in COPD may drive defective macrophage phenotype Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Distinct localization of estrogen receptors in lungs of severe COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Dual role of M2 macrophages in asthma Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Adiponectin acts as an anti-inflammatory cytokine on human lung macrophages Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Macrophage phenotype does not affect protease anti-protease imbalance in COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 IL32 expression in induced sputum of COPD subjects Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages Source: International Congress 2016 – Mechanisms of disease Year: 2016 Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD Source: Eur Respir J 2016; 47: 1093-1102 Year: 2016 Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 The effect of in vitro culture methods on corticosteroid sensitivity in COPD alveolar macrophages Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Endothelin receptor antagonists (ERAs) neutralize LPS-induced cytokine release from pulmonary vascular smooth muscle cells (PVSMCs) by down-regulation of CD14 Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 CC and C chemokine expression in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: 1206-1212 Year: 2002 Characterization of M1 and M2 macrophages in human lung tissue Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Monocyte sub-populations do not reflect differences in COPD macrophage phenotype Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002 COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013